. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: Infect Control Hosp Epidemiol. 2015 Dec 21;37(3):281–288. doi: 10.1017/ice.2015.298

Table 3. Treatment characteristics.

	All	CRKP readmission	No CRKP readmission	p
n	160	30 (19)	130 (81)
*Any in vitro* active drug in first 7 days**
aminoglycoside	70 (44)	11 (37)	59 (45)	0.42
colistin	27 (17)	5 (17)	22 (17)	1.00
tigecycline	76 (48)	20 (67)	56 (43)	0.03
trimethoprim/sulfamethoxazole	14 (9)	1 (3)	13 (10)	0.47
fosfomycin	17 (11)	7 (23)	10 (8)	0.02
Base of regimen
aminoglycoside	70 (44)	11 (37)	59 (45)	0.42
colistin	22 (14)	3 (10)	19 (15)	0.77
tigecycline	49 (31)	14 (47)	35 (27)	0.047
other	19 (12)	2 (7)	17 (13)	0.53
*>1 in vitro* active drug in first 7 days**	42 (26)	13 (43)	29 (22)	0.02